Loading...
OTCM
HBRM
Market cap962kUSD
Jul 10, Last price  
0.00USD
1D
0.00%
1Q
0.00%
Jan 2017
0.00%
Name

Herborium Group Inc

Chart & Performance

D1W1MN
No data to show
P/E
32.62
P/S
0.86
EPS
0.00
Div Yield, %
Shrs. gr., 5y
10.64%
Rev. gr., 5y
6.52%
Revenues
1m
-1.21%
105,431,200104,938,70088,872,70075,011,70070,328,70074,327,00071,473,500827,755761,884843,200908,600816,300875,000993,5001,051,0001,133,1001,119,420
Net income
30k
P
1,775,700827,300121,800-2,850,700-2,835,900-2,128,400-1,892,200-339,757-642,555-54,700-32,200-174,100-76,00047,100-328,770-267,04029,523
CFO
370k
P
-2,191,3003,582,8001,161,500-1,634,000-898,000-470,400-1,896,900-24,093-86,0198,80079,600-117,500-71,000-43,40094,100-133,290369,970

Profile

Herborium Group, Inc., a botanical therapeutics company, develops, licenses, and markets proprietary, botanical based medicinal products to consumers and healthcare professionals. It offers dermatology products, which include AcnEase, herbal medicinal product for enhancing conditions associated with hormonal acne and multiple symptoms of Rosacea; and AcnEase Skin Management System for the treatment of acne marks/scars. The company also provides sexual health and performance products that are non-prescriptive alternatives to selected sexual disorders resulting from cardiovascular disease, use of anti-depressants, and surgical procedures, including hysterectomy. In addition, it offers energy restoration products, such as Lasting Energy, a herbal supplement to decrease the symptoms associated with hangovers and eliminating jet-lag; and for treating overall depletion of energy due to competitive sports, high levels of stress, and extensive sexual activities, as well as other long term or temporary physical demands. Further, the company provides Liver Activator Series for the treatment of liver damage; ProstAid, a natural product focuses on Benign Prostate Hyperplasia; and CardioVitae, a fermentation based product using a Lucidium derived cell line targeting cardio-pulmonary insufficiencies. Herborium Group, Inc. sells its products in the United States, the United Kingdom, and continental Europe through a network of distributors, specialty retailers, and e-commerce. The company was founded in 2000 and is headquartered in Fort Lee, New Jersey.
IPO date
Jul 10, 1998
Employees
2
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFY
2023‑112022‑112021‑112020‑112019‑112018‑112017‑112016‑11
Income
Revenues
1,119
-1.21%
1,133
7.81%
Cost of revenue
531
462
Unusual Expense (Income)
NOPBT
589
671
NOPBT Margin
52.59%
59.24%
Operating Taxes
(168)
Tax Rate
NOPAT
757
671
Net income
30
-111.06%
(267)
-18.78%
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
402
402
Long-term debt
668
650
Deferred revenue
Other long-term liabilities
(1)
Net debt
1,059
1,038
Cash flow
Cash from operating activities
370
(133)
CAPEX
(2)
(2)
Cash from investing activities
(2)
(2)
Cash from financing activities
(371)
145
FCF
1,100
795
Balance
Cash
10
14
Long term investments
Excess cash
Stockholders' equity
(15,040)
(15,041)
Invested Capital
11,793
12,137
ROIC
6.32%
9.22%
ROCE
EV
Common stock shares outstanding
10,737,131
9,686,973
Price
Market cap
EV
EBITDA
589
676
EV/EBITDA
Interest
Interest/NOPBT